The passing of Sally Barollet, a 27-year-old from Dijon, Burgundy, has drawn international attention to the complex debate surrounding assisted suicide and the impact of rare medical conditions on quality of life. Sally passed away in Switzerland in late 2025 (with memorials continuing into April 2026) after choosing to end her life following a lifelong struggle with a severe nevus condition.
Background and Condition
The Diagnosis: Sally lived with a Giant Congenital Melanocytic Nevus (GCMN), a rare condition characterized by large, dark, non-cancerous skin patches that can cover significant portions of the body.
Health Struggles: Beyond the physical appearance, the condition caused Sally chronic physical pain, persistent itching, and significant psychological distress. She underwent over 30 surgeries throughout her life in attempts to treat the condition and manage its complications.
The “Invisible” Battle: Sally was a vocal advocate on social media, using her platform to highlight that her suffering was not just “skin deep” but involved neurological issues and a constant state of physical discomfort that traditional medicine could no longer alleviate.
The Decision for Assisted Suicide
In 2024 and 2025, Sally began sharing her journey toward seeking assisted dying, a procedure that is currently illegal in France but legal under specific circumstances in Switzerland.
The Reason: Sally stated that she had reached a point where her “quality of life had vanished.” She expressed that she wanted to “die with dignity” before her condition or the mental toll of the pain became even more unbearable.
The Location: Because French law did not permit medical assistance in dying for her specific circumstances at the time, she traveled to a clinic in Switzerland to carry out her final wish.
Final Message: In her final public communications, she emphasized that her choice was one of “liberation” and urged for more compassion and legal options for those suffering from incurable, non-terminal conditions that cause “unbearable” distress.
Community and Global Impact
Advocacy: Sally’s story became a focal point in the legislative debate in France regarding the “End of Life” (Fin de Vie) bill. Her testimony was frequently cited by activists who believe patients should have the right to choose their time of death.
Tributes: Following her passing, the Association Nevus France and various support groups for rare skin conditions paid tribute to her bravery. She is remembered not just for how she died, but for her courage in showing the world the reality of living with a disfiguring and painful rare disease.
Memorials: In Dijon, her family and friends held private ceremonies to honor her memory, describing her as a “shining light” who fought a long and difficult battle with grace.
Cause of Death
The official cause of death was physician-assisted suicide via the administration of a lethal dose of barbiturates, a standard legal procedure in Swiss right-to-die clinics.
Sally Barollet’s legacy continues through the conversations she started about body autonomy, the ethics of assisted dying, and the need for better support systems for those living with rare, chronic conditions.
